These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2642088)

  • 1. Lipid abnormalities and immunodeficiency in familial erythrophagocytic lymphohistiocytosis.
    Ladisch S
    Pediatr Hematol Oncol; 1989; 6(3):283-9. PubMed ID: 2642088
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal T-cell phenotype in familial erythrophagocytic lymphohistiocytosis.
    Bujan W; Schandene L; Ferster A; De Valck C; Goldman M; Sariban E
    Lancet; 1993 Nov; 342(8882):1296. PubMed ID: 7901594
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemophagocytic lymphohistiocytosis as a syndrome: correlation of clinicopathological data.
    Nezelof C
    Pediatr Hematol Oncol; 1989; 6(3):207-11. PubMed ID: 2642078
    [No Abstract]   [Full Text] [Related]  

  • 4. On the pathogenesis of perforin defects and related immunodeficiencies.
    Moretta L; Moretta A; Hengartner H; Zinkernagel RM
    Immunol Today; 2000 Nov; 21(11):593-4. PubMed ID: 11221685
    [No Abstract]   [Full Text] [Related]  

  • 5. [Farquhar disease. Reduced phagocyte function in a 9-year-old girl with erythrophagocytic lymphohistiocytosis].
    Schroten H; Kampmann A; Sperzel M; Jürgens H; Seger R; Wahn V
    Monatsschr Kinderheilkd; 1992 Jun; 140(6):336-9. PubMed ID: 1640943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial erythrophagocytic lymphohistiocytosis].
    Erina TA; Minkov M; Sartan LV
    Pediatriia; 1992; (2):87-9. PubMed ID: 1513641
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of familial hemophagocytic lymphohistiocytosis].
    Sako M
    Rinsho Ketsueki; 1999 Feb; 40(2):88-91. PubMed ID: 10199198
    [No Abstract]   [Full Text] [Related]  

  • 8. [Genetic defects in control of T cell activation evolving in a syndrome of lymphohistiocytic activation].
    Dufourcq-Lagelouse R; Pastural E; Barrat FJ; Le Deist F; Fischer A; de Saint Basile G
    Arch Pediatr; 1999; 6 Suppl 2():417s-419s. PubMed ID: 10370555
    [No Abstract]   [Full Text] [Related]  

  • 9. Natural killer cell function and interferon production in familial hemophagocytic lymphohistiocytosis.
    Eife R; Janka GE; Belohradsky BH; Holtmann H
    Pediatr Hematol Oncol; 1989; 6(3):265-72. PubMed ID: 2642085
    [No Abstract]   [Full Text] [Related]  

  • 10. CT and MR findings in familial erythrophagocytic lymphohistiocytosis.
    Huddle DC; Rosenblum JD; Diamond CK
    AJR Am J Roentgenol; 1994 Jun; 162(6):1504-5. PubMed ID: 8192058
    [No Abstract]   [Full Text] [Related]  

  • 11. Familial erythrophagocytic lymphohistiocytosis: neuroradiologic evaluation with pathologic correlation.
    Kollias SS; Ball WS; Tzika AA; Harris RE
    Radiology; 1994 Sep; 192(3):743-54. PubMed ID: 8058942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial erythrophagocytic lymphohistiocytosis: late relapse despite continuous high-dose VP-16 chemotherapy.
    Ware R; Friedman HS; Kinney TR; Kurtzberg J; Chaffee S; Falletta JM
    Med Pediatr Oncol; 1990; 18(1):27-9. PubMed ID: 2294389
    [No Abstract]   [Full Text] [Related]  

  • 13. Natural killer deficiency: a minor or major factor in the manifestation of hemophagocytic lymphohistiocytosis?
    Schneider EM; Lorenz I; Walther P; Janka-Schaub GE
    J Pediatr Hematol Oncol; 2003 Sep; 25(9):680-3. PubMed ID: 12972801
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemophagocytic syndromes and primary immunodeficiencies].
    Stéphan JL
    Arch Pediatr; 2003 Sep; 10 Suppl 4():517s-520s. PubMed ID: 14763336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodeficiency in familial erythrophagocytic lymphohistiocytosis.
    Ammann AJ; Addiego J
    Lancet; 1978 Oct; 2(8093):789-90. PubMed ID: 80713
    [No Abstract]   [Full Text] [Related]  

  • 16. Heterogeneity of immune markers in hemophagocytic lymphohistiocytosis: comparative study of 9 familial and 14 familial inheritance-unproved cases.
    Imashuku S; Hibi S; Sako M; Ishii T; Kohdera U; Kitazawa K; Ooe K; Naya M; Sawada H; Kawakami T
    J Pediatr Hematol Oncol; 1998; 20(3):207-14. PubMed ID: 9628431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of familial erythrophagocytic lymphohistiocytosis with cyclosporine A.
    Abella EM; Artrip J; Schultz K; Ravindranath Y
    J Pediatr; 1997 Mar; 130(3):467-70. PubMed ID: 9063426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythrophagocytic histiocytosis syndrome in a child with a primary immunodeficit].
    Pavlovskaia AI; Simonova OI
    Arkh Patol; 1989; 51(4):75-9. PubMed ID: 2742535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hemophagocytic lymphohistiocytosis macrophages showing immunohistochemical properties of activated macrophages and T-accessory cells.
    Hansmann ML; Rontogianni D; Janka-Schaub GE; Wacker HH; Hinkeldey K; Radzun HJ
    Pediatr Hematol Oncol; 1989; 6(3):237-46. PubMed ID: 2642082
    [No Abstract]   [Full Text] [Related]  

  • 20. Familial haemophagocytic lymphohistiocytosis treated with allogeneic bone marrow transplantation.
    Nespoli L; Locatelli F; Bonetti F; Porta F; Zecca M; Gibardi A; Gambarana D; Vitale V; Burgio GR; Severi F
    Bone Marrow Transplant; 1991; 7 Suppl 3():139-42. PubMed ID: 1855079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.